We are live on ! Find out more
ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

76 hedge funds and large institutions have $56.8M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $1.86M | Put options by funds: $882K

27% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 22

10% less funds holding

Funds holding: 84 → 76 (-8)

13% less capital invested

Capital invested by funds: $65M → $56.8M (-$8.25M)

44% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 18

Holders
76
Holders Change
-8
Holders Change %
-9.52%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
28
Reduced
22
Closed
18
Calls
$1.86M
Puts
$882K
Net Calls
+$975K
Net Calls Change
+$1.72M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.05M
2
Wells Fargo
Wells Fargo
California
+$905K
3
Millennium Management
Millennium Management
New York
+$680K
4
ECM
ExodusPoint Capital Management
New York
+$677K
5
Renaissance Technologies
Renaissance Technologies
New York
+$375K

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$1.37M
2
ACM
Altium Capital Management
New York
-$818K
3
JGC
J. Goldman & Co
New York
-$587K
4
ACA
Apis Capital Advisors
New York
-$570K
5
Two Sigma Investments
Two Sigma Investments
New York
-$415K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$434K +$339K +4,096 +371%
Principal Financial Group
27
Principal Financial Group
Iowa
$353K -$8.85K -107 -2%
Citadel Advisors
28
Citadel Advisors
Florida
$350K +$64.7K +782 +23%
Prudential Financial
29
Prudential Financial
New Jersey
$320K +$317K +3,835 New
IC
30
IEQ Capital
California
$301K – – –
VWM
31
Vigilare Wealth Management
Arizona
$265K +$45.2K +546 +21%
Ameriprise
32
Ameriprise
Minnesota
$259K -$23.4K -283 -8%
Bank of America
33
Bank of America
North Carolina
$241K +$10.4K +126 +5%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$230K +$5.71K +69 +3%
Simplex Trading
35
Simplex Trading
Illinois
$226K – – –
Envestnet Asset Management
36
Envestnet Asset Management
Illinois
$209K -$207K -2,500 -50%
Mercer Global Advisors
37
Mercer Global Advisors
Colorado
$209K -$207K -2,500 -50%
Creative Planning
38
Creative Planning
Kansas
$184K +$86.6K +1,047 +91%
JP Morgan Chase
39
JP Morgan Chase
New York
$171K +$99.3K +1,200 +141%
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$161K +$160K +1,933 New
VFA
41
Valeo Financial Advisors
Indiana
$144K +$143K +1,727 New
IIA
42
IPG Investment Advisors
California
$128K -$1.41K -17 -1%
AAM
43
Aureus Asset Management
Massachusetts
$126K – – –
Osaic Holdings
44
Osaic Holdings
Arizona
$117K +$10.8K +131 +10%
SG Americas Securities
45
SG Americas Securities
New York
$111K +$47K +568 +74%
TCWM
46
Total Clarity Wealth Management
Illinois
$110K +$109K +1,322 New
Deutsche Bank
47
Deutsche Bank
Germany
$106K -$169K -2,046 -62%
AIG
48
American International Group
New York
$101K -$2.4K -29 -2%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$100K +$99.1K +1,198 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$99K -$154K -1,865 -61%
1
2
3 4

ONCT Hedge Fund Activity: Q3 2021 in Review

76 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q3 2021, worth a combined $56.8M — down 13% from $65M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ONCT and 10 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 28 added.

The largest buyer was Morgan Stanley, adding an estimated $1.05M. The largest seller was Norges Bank, cutting an estimated $1.37M.

  • 76 institutional investors held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q3 2021, down from 84 in Q2 2021.
  • Funds reported $56.8M of Oncternal Therapeutics, Inc. Common Stock stock for Q3 2021, down 13% quarter-over-quarter.
  • 10 funds opened new Oncternal Therapeutics, Inc. Common Stock positions in Q3 2021 and 18 closed out, a net change of -8 holders.
  • The largest Oncternal Therapeutics, Inc. Common Stock buyer in Q3 2021 was Morgan Stanley, an estimated $1.05M added.
  • The largest Oncternal Therapeutics, Inc. Common Stock seller in Q3 2021 was Norges Bank, an estimated $1.37M sold.

Based on aggregated 13F filings for Q3 2021.